Monomeric adiponectin modulates nitric oxide release and calcium movements in porcine aortic endothelial cells in normal/high glucose conditions

AimsPerivascular adipose tissue can be involved in the process of cardiovascular pathology through the release of adipokines, namely adiponectins. Monomeric adiponectin has been shown to increase coronary blood flow in anesthetized pigs through increased nitric oxide (NO) release and the involvement of adiponectin receptor 1 (AdipoR1). The present study was therefore planned to examine the effects of monomeric adiponectin on NO release and Ca2 + transients in porcine aortic endothelial cells (PAEs) in normal/high glucose conditions and the related mechanisms.Main methodsPAEs were treated with monomeric adiponectin alone or in the presence of intracellular kinases blocker, AdipoR1 and Ca2 +-ATPase pump inhibitors. The role of Na+/Ca2 + exchanger was examined in experiments performed in zero Na+ medium. NO release and intracellular Ca2 + were measured through specific probes.Key findingsIn PAE cultured in normal glucose conditions, monomeric adiponectin elevated NO production and [Ca2 +]c. Similar effects were observed in high glucose conditions, although the response was lower and not transient. The Ca2 + mobilized by monomeric adiponectin originated from an intracellular pool thapsigargin- and ATP-sensitive and from the extracellular space. Moreover, the effects of monomeric adiponectin were prevented by kinase blockers and AdipoR1 inhibitor. Finally, in normal glucose condition, a role for Na+/Ca2 + exchanger and Ca2 +-ATPase pump in restoring Ca2 + was found.SignificanceOur results add new information about the control of endothelial function elicited by monomeric adiponectin, which would be achieved by modulation of NO release and Ca2 + transients. A signalling related to Akt, ERK1/2 and p38MAPK downstream AdipoR1 would be involved.